Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting TIME in advanced hepatocellular carcinoma: Mechanisms of drug resistance and treatment strategies

16 Apr 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Hepatocellular Carcinoma Treatment and Prognosis
Share to Liver Disease Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40250780
DOI: 10.1016/j.critrevonc.2025.104735

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting TIME in advanced hepatocellular carcinoma: Mechanisms of drug resistance and treatment strategiesPMID 40250780Read ↗

Targeted therapy for hepatocellular carcinoma: Challenges and opportunitiesSemantic proximity Read ↗

Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic AspectsSemantic proximity Read ↗

Mechanisms of drug resistance in hepatocellular carcinomaSemantic proximity Read ↗

Advances in targeted therapies for hepatocellular carcinoma in the genomic era.Semantic proximity Read ↗

Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents.Semantic proximity Read ↗

Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic responseSemantic proximity Read ↗

MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular CarcinomaSemantic proximity Read ↗

Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic HeterogeneitySemantic proximity Read ↗

Drug Targets and Molecular Mechanisms of Drug Resistance in Chronic Hepatitis BSemantic proximity Read ↗

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageSemantic proximity Read ↗

Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: Mechanistical and pharmacological perspectivesSemantic proximity Read ↗

Coordinated activation of DNMT3a and TET2 in cancer stem cell-like cells initiates and sustains drug resistance in hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.